Table I.
Clinicopathological features | Total (n=200) | Viscera (n=65) | Head and neck (n=64) | Soft tissue (n=37) | Breast (n=33) |
---|---|---|---|---|---|
Male/female | 97/103 | 32/33 | 44/20 | 20/17 | 1/32 |
Mean age, years | 52.3 | 45.5 | 66.0 | 52.6 | 38.6 |
<65 | 137 | 55 | 25 | 25 | 31 |
≥65 | 63 | 10 | 39 | 12 | 2 |
Mean size, cm | 5.2 | 6.4 | 4.5 | 4.6 | 5.1 |
<5 | 57 | 12 | 15 | 18 | 12 |
≥5 | 50 | 19 | 13 | 9 | 9 |
Unknown | 93 | 34 | 36 | 10 | 12 |
Tumor differentiation | |||||
High grade | 94 | 29 | 42 | 20 | 3 |
Low grade | 106 | 36 | 22 | 17 | 30 |
Epithelioid appearance | 37 | 14 | 10 | 13 | 0 |
Tumor recurrence/metastasis | |||||
Yes | 63 | 21 | 14 | 16 | 12 |
No | 50 | 15 | 15 | 9 | 11 |
Unknown | 87 | 29 | 35 | 12 | 20 |
Metastatic site | |||||
Bone | 18 | 11 | 3 | 3 | 1 |
Lung | 18 | 5 | 2 | 9 | 2 |
Liver | 8 | 6 | 2 | 0 | 0 |
Lymph node | 8 | 4 | 2 | 2 | 0 |
Trunk | 6 | 0 | 0 | 2 | 4 |
Parotid gland | 4 | 0 | 4 | 0 | 0 |
Breast | 3 | 0 | 0 | 0 | 3 |
Retroperitoneum | 2 | 2 | 0 | 0 | 0 |
Pleura | 1 | 1 | 0 | 0 | 0 |
Spleen | 1 | 1 | 0 | 0 | 0 |
Treatment modality | |||||
Multimodal therapy | 56 | 18 | 11 | 13 | 14 |
Surgery + radiotherapy | 18 | 5 | 5 | 4 | 4 |
Surgery + chemotherapy | 33 | 12 | 5 | 9 | 7 |
Surgery + radiotherapy + chemotherapy | 5 | 1 | 1 | 0 | 3 |
Non-multimodal therapy | 67 | 22 | 20 | 14 | 11 |
Surgery | 64 | 21 | 18 | 14 | 11 |
Radiotherapy | 2 | 1 | 1 | 0 | 0 |
Chemotherapy | 1 | 0 | 1 | 0 | 0 |
Unknown | 77 | 25 | 33 | 10 | 8 |
Survival, % | |||||
5-year disease-free survival | 19.3 | 19.0 | 0 | 18.7 | 34.8 |
5-year overall survival | 40.8 | 37.0 | 28.0 | 36.6 | 87.5 |